🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with tirzepatide cardiovascular safety? Page 5

Has anyone dealt with tirzepatide cardiovascular safety?

carlos_SATX Thu, Sep 18, 2025 at 10:20 PM 41 replies 1,657 viewsPage 5 of 9
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Sep 21, 2025 at 9:31 PM#21

A narrower follow-up, since the general answer is now clear:

How much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical?

3 3RunnerRach, TrialNerd_Beth, HPLC_Greg
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Sep 22, 2025 at 4:28 PM#22
Dr.EndoEP said:
The useful move here is to separate what is established from what is widely repeated.

I read this differently from Dr.EndoEP, on substance rather than tone. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

2 2TinaHashiRN, robert_kc
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Sep 23, 2025 at 11:25 AM#23
Dr.EndoEP said:
The useful move here is to separate what is established from what is widely repeated.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

Last edited: Sep 23, 2025 at 4:25 PM
1 1josh_phd_bmore
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Sep 24, 2025 at 6:23 AM#24
Dr.EndoEP said:
The useful move here is to separate what is established from what is widely repeated.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

Last edited: Sep 24, 2025 at 9:23 AM
50 0LondonLisa, mike_nyc, VendorMark and 47 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Sep 25, 2025 at 1:21 AM#25

Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

49 24kim_atl_prep, sarah_TO, wendy_avl and 46 others
Reply Quote Save Share Report
1345679

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register